<PAGE>
EXHIBIT 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the use in this Registration Statement on Form S-1 of
our report dated March 6, 2000, except as to the one-for-six reverse stock split
described in Note 1, which is as of March 24, 2000, the additional beneficial
conversion feature dividend described in Note 8, which is as of April 3, 2000
and Note 11, which is as of August 7, 2000, relating to the consolidated
financial statements of DrugAbuse Sciences, Inc. and its subsidiary (companies
in the development stage), which appear in such Registration Statement. We also
consent to the reference to us under the heading "Experts" in such Registration
Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
September 15, 2000
